Literature DB >> 7934427

Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception.

P Y Robillard1, T C Hulsey, J Périanin, E Janky, E H Miri, E Papiernik.   

Abstract

Pregnancy-induced hypertension affects at least 10% of all pregnancies. An association with first pregnancy or a change in paternity for subsequent pregnancies has been suggested. We studied the duration of sexual cohabitation with the father prior to conception and the incidence of pregnancy-induced hypertension. During a five-month period, 1011 consecutive women who delivered in an obstetric unit were interviewed about paternity and duration of sexual cohabitation before conception. Obstetric charts were abstracted to identify three groups: those with pregnancy-induced hypertension, chronic hypertension, and normal blood pressure. The incidence of pregnancy-induced hypertension was 11.9% among primigravidae, 4.7% among same-paternity multigravidae, and 24.0% among new-paternity multigravidae. For both primigravidae and multigravidae, length of sexual cohabitation before conception was inversely related to the incidence of pregnancy-induced hypertension (p < 0.0001). Similar results were observed after control for race, education, maternal age, marital status, and number of pregnancies. Pregnancy-induced hypertension may be a problem of primipaternity rather than primigravidity. Furthermore, an extended duration of sexual cohabitation before conception may protect against pregnancy-induced hypertension.

Entities:  

Mesh:

Year:  1994        PMID: 7934427     DOI: 10.1016/s0140-6736(94)91638-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  38 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa.

Authors:  Elizabeth W Triche; Karisa K Harland; Elizabeth H Field; Linda M Rubenstein; Audrey F Saftlas
Journal:  J Reprod Immunol       Date:  2013-08-06       Impact factor: 4.054

3.  Correlative research of the incidence of preeclampsia and sperm exposure.

Authors:  Dibing Zhu; Yang Song; Qingqing Ding; Cuicui Duan; Wei Wu; Jian Xu
Journal:  Arch Gynecol Obstet       Date:  2021-05-23       Impact factor: 2.344

Review 4.  Preeclampsia: a view through the danger model.

Authors:  Elizabeth A Bonney
Journal:  J Reprod Immunol       Date:  2007-05-04       Impact factor: 4.054

5.  Male reproductive proteins and reproductive outcomes.

Authors:  Roberta B Ness; David A Grainger
Journal:  Am J Obstet Gynecol       Date:  2008-01-14       Impact factor: 8.661

6.  Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice.

Authors:  Sarah A Robertson; Leigh R Guerin; John J Bromfield; Kim M Branson; Aisling C Ahlström; Alison S Care
Journal:  Biol Reprod       Date:  2009-01-21       Impact factor: 4.285

7.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

8.  A new mouse model to explore therapies for preeclampsia.

Authors:  Abdulwahab Ahmed; Jameel Singh; Ysodra Khan; Surya V Seshan; Guillermina Girardi
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 9.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

10.  Specific subsets of immune cells in human decidua differ between normal pregnancy and preeclampsia--a prospective observational study.

Authors:  Lorenz Rieger; Sabine Segerer; Thomas Bernar; Michaela Kapp; Monika Majic; Ann-Katrin Morr; Johannes Dietl; Ulrike Kämmerer
Journal:  Reprod Biol Endocrinol       Date:  2009-11-23       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.